Cargando…

Utilization of ethanolamine phosphate phospholyase as a unique astrocytic marker

Astrocytes play diverse roles in the central nervous system (CNS) in both physiological and pathological conditions. Previous studies have identified many markers of astrocytes to analyze their complicated roles. Recently, closure of the critical period by mature astrocytes has been revealed, and th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsujioka, Hiroshi, Yamashita, Toshihide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922850/
https://www.ncbi.nlm.nih.gov/pubmed/36794261
http://dx.doi.org/10.3389/fncel.2023.1097512
_version_ 1784887617773371392
author Tsujioka, Hiroshi
Yamashita, Toshihide
author_facet Tsujioka, Hiroshi
Yamashita, Toshihide
author_sort Tsujioka, Hiroshi
collection PubMed
description Astrocytes play diverse roles in the central nervous system (CNS) in both physiological and pathological conditions. Previous studies have identified many markers of astrocytes to analyze their complicated roles. Recently, closure of the critical period by mature astrocytes has been revealed, and the need for finding mature astrocyte-specific markers has been growing. We previously found that Ethanolamine phosphate phospholyase (Etnppl) was almost not expressed in the developing neonatal spinal cord, and its expression level slightly decreased after pyramidotomy in adult mice, which showed weak axonal sprouting, suggesting that its expression level negatively correlates with axonal elongation. Although the expression of Etnppl in astrocytes in adult is known, its utility as an astrocytic marker has not yet been investigated in detail. Here, we showed that Etnppl was selectively expressed in astrocytes in adult. Re-analyses using published RNA-sequencing datasets revealed changes in Etnppl expression in spinal cord injury, stroke, or systemic inflammation models. We produced high-quality monoclonal antibodies against ETNPPL and characterized ETNPPL localization in neonatal and adult mice. Expression of ETNPPL was very weak in neonatal mice, except in the ventricular and subventricular zones, and it was heterogeneously expressed in adult mice, with the highest expression in the cerebellum, olfactory bulb, and hypothalamus and the lowest in white matter. Subcellular localization of ETNPPL was dominant in the nuclei with weak expression in the cytosol in the minor population. Using the antibody, astrocytes in adult were selectively labeled in the cerebral cortex or spinal cord, and changes in astrocytes were detected in the spinal cord after pyramidotomy. ETNPPL is expressed in a subset of Gjb6(+) astrocytes in the spinal cord. The monoclonal antibodies we created, as well as fundamental knowledge characterized in this study, will be valuable resources in the scientific community and will expand our understanding of astrocytes and their complicated responses in many pathological conditions in future analyses.
format Online
Article
Text
id pubmed-9922850
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99228502023-02-14 Utilization of ethanolamine phosphate phospholyase as a unique astrocytic marker Tsujioka, Hiroshi Yamashita, Toshihide Front Cell Neurosci Neuroscience Astrocytes play diverse roles in the central nervous system (CNS) in both physiological and pathological conditions. Previous studies have identified many markers of astrocytes to analyze their complicated roles. Recently, closure of the critical period by mature astrocytes has been revealed, and the need for finding mature astrocyte-specific markers has been growing. We previously found that Ethanolamine phosphate phospholyase (Etnppl) was almost not expressed in the developing neonatal spinal cord, and its expression level slightly decreased after pyramidotomy in adult mice, which showed weak axonal sprouting, suggesting that its expression level negatively correlates with axonal elongation. Although the expression of Etnppl in astrocytes in adult is known, its utility as an astrocytic marker has not yet been investigated in detail. Here, we showed that Etnppl was selectively expressed in astrocytes in adult. Re-analyses using published RNA-sequencing datasets revealed changes in Etnppl expression in spinal cord injury, stroke, or systemic inflammation models. We produced high-quality monoclonal antibodies against ETNPPL and characterized ETNPPL localization in neonatal and adult mice. Expression of ETNPPL was very weak in neonatal mice, except in the ventricular and subventricular zones, and it was heterogeneously expressed in adult mice, with the highest expression in the cerebellum, olfactory bulb, and hypothalamus and the lowest in white matter. Subcellular localization of ETNPPL was dominant in the nuclei with weak expression in the cytosol in the minor population. Using the antibody, astrocytes in adult were selectively labeled in the cerebral cortex or spinal cord, and changes in astrocytes were detected in the spinal cord after pyramidotomy. ETNPPL is expressed in a subset of Gjb6(+) astrocytes in the spinal cord. The monoclonal antibodies we created, as well as fundamental knowledge characterized in this study, will be valuable resources in the scientific community and will expand our understanding of astrocytes and their complicated responses in many pathological conditions in future analyses. Frontiers Media S.A. 2023-01-30 /pmc/articles/PMC9922850/ /pubmed/36794261 http://dx.doi.org/10.3389/fncel.2023.1097512 Text en Copyright © 2023 Tsujioka and Yamashita. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Tsujioka, Hiroshi
Yamashita, Toshihide
Utilization of ethanolamine phosphate phospholyase as a unique astrocytic marker
title Utilization of ethanolamine phosphate phospholyase as a unique astrocytic marker
title_full Utilization of ethanolamine phosphate phospholyase as a unique astrocytic marker
title_fullStr Utilization of ethanolamine phosphate phospholyase as a unique astrocytic marker
title_full_unstemmed Utilization of ethanolamine phosphate phospholyase as a unique astrocytic marker
title_short Utilization of ethanolamine phosphate phospholyase as a unique astrocytic marker
title_sort utilization of ethanolamine phosphate phospholyase as a unique astrocytic marker
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922850/
https://www.ncbi.nlm.nih.gov/pubmed/36794261
http://dx.doi.org/10.3389/fncel.2023.1097512
work_keys_str_mv AT tsujiokahiroshi utilizationofethanolaminephosphatephospholyaseasauniqueastrocyticmarker
AT yamashitatoshihide utilizationofethanolaminephosphatephospholyaseasauniqueastrocyticmarker